E11 Bio (http://e11.bio) is a non-profit Focused Research Organization developing next-generation technologies to accelerate neuroscience and improve human health. We are making single-cell brain circuit mapping a routine and accessible part of every neuroscientist’s toolbox.We are a part of Convergent Research (https://convergentresearch.org/) and supported by Schmidt Futures (https://www.schmidtfutures.com/).

IndieBio (http://indiebio.co/) is the world's leading seed-stage life science accelerator. Based in San Francisco and New York City, our program trains scientists to become entrepreneurs to solve the most pressing issues in human and planetary health.Our 4-month program includes $525K funding, fully-equipped labs, and dedicated mentorship. During my tenure, we funded and advised over 170 biotech companies across all sectors. Notable alumni include: • food - Upside Foods, NotCo, The EVERY Company, Prime Roots, New Culture, Endless West• sustainable agriculture - Beeflow, NovoNutrients, Vertical Oceans• consumer biotech - Geltor, OneSkin, Sun Genomics• computational biology - Catalog Technologies, Gatehouse Bio• therapeutics - SyntheX, Prellis Biologics, Indee Labs• biomaterials - MycoWorks, Huue, Lingrove

Next-generation multiplex proteomics profiling technology for precision medicine• Designed and performed proof-of-principle experiments• Managed lab operations and collaborations

Lab automation robotics startup to accelerate biological research• Biology and chemistry generalist for oligo synthesis and CRISPR/Cas9 products• Product development, optimization, troubleshooting, and experimental design• Lab robotics programming and operations; data and visualization in Python

Science toys for education and outreach• Designed and commercialized interactive DNA molecule plush toys• Managed overseas manufacturing and shipping logistics

Biotech company pioneering cell-free synthesis technology for the development of antibody-drug conjugates, bispecific antibodies, and immuno-oncology drugs• Developed and performed high-throughput screening assays for antibody discovery• Biophysical characterization of antibodies and bispecific antibodies• Optimized cell-free synthesis for engineered antibody scaffolds• Performed protein conjugations

Advisor: Peter G. Schultz• Developed in vitro and in vivo applications of genetically encoded unnatural amino acids• Synthesized site-specific antibody-drug conjugates and bispecific antibodies for selective treatment of cancer

Advisor: Thomas J. Tolbert• Synthesized post-translationally modified peptides using biological and chemical approaches• Cloned and purified glycan and glycoprotein processing enzymes